Nuvalent Income Statement

Financials in millions USD. Fiscal year is January - December.

Millions USD. Fiscal year is Jan - Dec.

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Mar '26 Mar 31, 2026	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
Selling, General & Admin	122.74	107.34	62.59	36.25	22.38	10.26
Research & Development	316.16	306.97	217.77	113.24	63.73	35.56
Operating Expenses	438.9	414.31	280.37	149.49	86.11	45.82
Operating Income	-438.9	-414.31	-280.37	-149.49	-86.11	-45.82
Interest & Investment Income	34.66	33.63	23.65	13.16	3.88	0.33
Other Non Operating Income (Expenses)	-56.34	-55.22	-17.94	-	-	-0.64
EBT Excluding Unusual Items	-460.59	-435.9	-274.66	-136.33	-82.23	-46.12
Gain (Loss) on Sale of Investments	11.11	11.11	14.67	10.11	0.37	-0.22
Pretax Income	-449.48	-424.79	-259.99	-126.22	-81.85	-46.34
Income Tax Expense	0.6	0.59	0.76	-	-	-
Net Income	-450.07	-425.38	-260.76	-126.22	-81.85	-46.34
Net Income to Common	-450.07	-425.38	-260.76	-126.22	-81.85	-46.34
Net Income Growth	-	-	-	-	-	-
Shares Outstanding (Basic)	74	73	66	58	50	22
Shares Outstanding (Diluted)	74	73	66	58	50	22
Shares Change	9.05%	9.45%	14.06%	17.22%	128.01%	659.75%
EPS (Basic)	-6.05	-5.85	-3.93	-2.17	-1.65	-2.13
EPS (Diluted)	-6.05	-5.85	-3.93	-2.17	-1.65	-2.13
EPS Growth	-	-	-	-	-	-

Additional Metrics

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Mar '26 Mar 31, 2026	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
EBIT	-438.9	-414.31	-280.37	-149.49	-86.11	-45.82

SEC Filings: 10-K · 10-Q